KONINKLIJKE HEIJMANS NV CVA financials
KONINKLIJKE HEIJMANS NV CVA
Country: NL Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
724500OUE3PCA809DZ79 ISIN: NL0009269109 Financial statements
(EUR, as reported — unscaled; 100 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Cost of sales | €2.33B | €2.25B |
| Gross profit | €439.8M | €338.4M |
| Other income | €2.3M | €14.0M |
| Administrative expenses | €234.9M | €194.7M |
| Operating profit (EBIT) | €162.2M | €111.0M |
| Finance costs | €9.9M | €13.9M |
| Profit before tax | €175.6M | €117.0M |
| Income tax expense | €45.4M | €27.0M |
| Profit for the year | €130.2M | €90.0M |
| Total comprehensive income | €130.2M | €90.0M |
| Per share | ||
| Basic EPS | €4.73 | €3.31 |
| Diluted EPS | €4.73 | €3.31 |
| Free cash flow / share | €8.30 | €8.08 |
| Cash flow statement | ||
| Cash generated from operations | €335.6M | €284.5M |
| Net cash from operating activities | €272.3M | €249.2M |
| Income taxes paid | €57.0M | €29.0M |
| Net cash from investing activities | -€102.8M | -€59.1M |
| Purchase of PP&E (capex) | €43.9M | €29.4M |
| Purchase of intangibles | €0 | €1.0M |
| Net cash from financing activities | -€84.9M | -€125.1M |
| Dividends paid | €45.1M | €10.6M |
| Proceeds from borrowings | €600.0K | €0 |
| Repayments of borrowings | €1.6M | €79.9M |
| Lease liability payments | €38.8M | €34.6M |
| Balance sheet | ||
| Total assets | €1.67B | €1.37B |
| Non-current assets | €718.3M | €578.5M |
| Property, plant & equipment | €144.6M | €123.3M |
| Right-of-use assets | €123.7M | €106.0M |
| Intangible assets & goodwill | €187.2M | €164.8M |
| Current assets | €947.2M | €790.1M |
| Trade & other receivables | €245.4M | €213.4M |
| Cash & equivalents | €190.0M | €105.4M |
| Total equity | €548.3M | €463.0M |
| Non-current liabilities | €190.1M | €167.6M |
| Lease liabilities (non-current) | €89.6M | €74.9M |
| Current liabilities | €927.1M | €738.0M |
| Lease liabilities (current) | €34.5M | €31.7M |
| Trade & other payables | €446.2M | €367.3M |
| Deferred tax liabilities | €21.0M | €24.0M |
| Derived metrics | ||
| Free cash flow | €228.4M | €219.8M |
| Operating margin | 5.9% | 4.3% |
| Net margin | 4.7% | 3.5% |
| Return on equity | 23.7% | 19.4% |
| Cash conversion ratio | 2.09× | 2.77× |
| Capex coverage | 6.20× | 8.48× |
| Other reported items | ||
| Adjustments For Amortisation Expense | €2.2M | €10.0M |
| Adjustments For Decrease Increase In Inventories | -€10.8M | €14.7M |
| Adjustments For Finance Income | -€6.0M | -€7.7M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €8.1M | €800.0K |
| Adjustments For Income Tax Expense | -€45.4M | -€27.0M |
| Adjustments For Increase Decrease In Other Liabilities | €0 | €800.0K |
| Adjustments For Interest Expense | -€9.9M | -€13.9M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€1.2M | -€700.0K |
| Adjustments For Provisions | €5.5M | €3.9M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€17.3M | -€12.2M |
| Cash Advances and Loans Made To Related Parties | €67.0M | €32.9M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €24.7M | €8.1M |
| Cash Receipts From Repayment of Advances and Loans Made To Related Parties | €41.4M | €5.7M |
| Changes In Equity | €85.3M | €79.4M |
| Current Contract Assets | €119.5M | €93.5M |
| Current Contract Liabilities | €418.6M | €301.5M |
| Current Financial Liabilities | €100.0K | €400.0K |
| Current Recognised Liabilities Defined Benefit Plan | €1.2M | €1.5M |
| Current Tax Assets Current | €7.0M | €3.3M |
| Current Tax Liabilities Current | €200.0K | €5.4M |
| Deferred Tax Assets | €7.0M | €11.8M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €2370000.00 | — |
| Dividends Received From Investments Accounted For Using Equity Method Classified As Investing Activities | €7.5M | €4.8M |
| Dividends Recognised As Distributions To Owners Per Share | €1.64 | €0.89 |
| Equity and Liabilities | €1.67B | €1.37B |
| Finance Income | €6.0M | €7.7M |
| Increase Decrease In Cash and Cash Equivalents | €84.6M | €65.0M |
| Increase Decrease In Working Capital | -€113.5M | -€93.4M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €200.0K | €0 |
| Increase Decrease Through Transactions With Owners | -€44.9M | -€10.6M |
| Intangible Assets Other Than Goodwill | €27.1M | €2.2M |
| Interest Paid Classified As Operating Activities | €10.4M | €13.0M |
| Interest Received Classified As Operating Activities | €4.1M | €6.7M |
| Investment Accounted For Using Equity Method | €130.3M | €105.7M |
| Issued Capital | €8.3M | €8.3M |
| Noncurrent Contract Assets | €6.6M | €0 |
| Noncurrent Financial Liabilities | €8.3M | €8.2M |
| Noncurrent Provisions For Employee Benefits | €22.0M | €22.0M |
| Noncurrent Receivables Due From Joint Ventures | €91.8M | €64.7M |
| Other Comprehensive Income | €0 | €0 |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €0 | €0 |
| Other Expense By Function | €2.2M | €10.6M |
| Other Inventories | €172.8M | €141.6M |
| Other Longterm Provisions | €49.2M | €38.5M |
| Other Shortterm Provisions | €26.3M | €30.2M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €3.0M | €5.1M |
| Reserve of Remeasurements of Defined Benefit Plans | -€64.0M | -€64.0M |
| Reserve of Sharebased Payments | €400.0K | €200.0K |
| Retained Earnings Excluding Profit Loss For Reporting Period | €160.1M | €115.2M |
| Retained Earnings Profit Loss For Reporting Period | €130.2M | €90.0M |
| Revenue From Contracts With Customers | €2.77B | €2.58B |
| Selling Expense | €42.8M | €36.1M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €17.3M | €12.2M |
| Share Premium | €313.3M | €313.3M |
Methodology
Every line item above is a fact tagged in KONINKLIJKE HEIJMANS NV CVA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.